Yaozeng Xu

Yaozeng Xu


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Biomaterials
Verified
Journal Article
Closed access
HSHongguo Shao
Hongguo Shao
JSJi Shen
Ji Shen
MWMingjun Wang
Mingjun Wang
JCJingfu Cui
Jingfu Cui
YWYijun Wang
Yijun Wang
DGDechun Geng
Dechun Geng

1 October 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
ZPZichuan Ping
Zichuan Ping
ZWZhirong Wang
Zhirong Wang
JSJiawei Shi
Jiawei Shi
LWLiangliang Wang
Liangliang Wang
XGXiaobin Guo
Xiaobin Guo
DGDechun Geng
Dechun Geng

1 December 2010 in Injury
Verified
Journal Article
Closed access
YXYaozeng Xu
Yaozeng Xu
GDGeng Dechun
Geng Dechun
YHYang Huilin
Yang Huilin
ZGZhu Guangming
Zhu Guangming
WXWang Xianbin
Wang Xianbin

11 April 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
WZWei Zhou
Wei Zhou
YLYu Liu
Yu Liu
JSJining Shen
Jining Shen
BYBinqing Yu
Binqing Yu
JBJiaxiang Bai
Jiaxiang Bai
DGDechun Geng
Dechun Geng
Bone mass loss around prostheses is a major cause of implant failure, especially in postmenopausal osteoporosis patients. In osteoporosis, excess oxidative stress largely contributed abnormal bone remodeling. Melatonin, which is synthesized from the pineal gland, promotes osteoblast differentiation and bone formation and has effectively been used to combat oxidative stress. Thus, we determined if melatonin can inhibit oxidative stress to promote osteogenesis and improve bone mass around prostheses in osteoporosis. In this study, we observed that received melatonin at 50 mg/kg body weight significantly increased periprosthetic bone mass as well as implant fixation intensity in ovariectomized (OVX) rats. Meanwhile, it decreased the expression of oxidative stress markers (NAPDH oxidase 2 and cytochrome c) and enhanced expressing level of the formation markers of bones (alkaline phosphatase, osteocalcin, and osterix) around prostheses compared to that in the control group. Additionally, melatonin decreased hydrogen peroxide- (H2O2-) induced oxidative stress and restored the osteogenesis potential of MC3T3-E1 cells. Mechanistically, melatonin clearly increased mitochondrial sirtuin 3 (SIRT3) expression and decreased the ratio of acetylated superoxide dismutase 2 (AC-SOD2)/SOD2 compared to the H2O2group. SIRT3 inhibition counteracted the protective effects of melatonin on oxidative stress and bone formation. Together, the results showed that melatonin ameliorated oxidative stress in mitochondrial via the SIRT3/SOD2 signaling pathway, thereby promoting osteogenesis, improving bone mass around the prostheses, and increasing initial stability. Thus, melatonin might be a suitable candidate to decrease the rate of implant failure and lengthen the lifespan of prostheses after total joint arthroplasty.

31 October 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SZShijun Zhu
Shijun Zhu
XHXuanyang Hu
Xuanyang Hu
YTYunxia Tao
Yunxia Tao
ZPZichuan Ping
Zichuan Ping
LWLiangliang Wang
Liangliang Wang
DGDechun Geng
Dechun Geng
Wear-particle-induced chronic inflammation and osteoclastogenesis have been identified as critical factors of aseptic loosening. Although strontium is known to be involved in osteoclast differentiation, its effect on particle-induced inflammatory osteolysis remains unclear. In this study, we investigate the potential impact and underling mechanism of strontium on particle-induced osteoclast activation and chronic inflammation in vivo and in vitro. As expected, strontium significantly inhibited titanium particle-induced inflammatory infiltration and prevented bone loss in a murine calvarial osteolysis model. Interestingly, the number of mature osteoclasts decreased after treatment with strontium in vivo, suggesting osteoclast formation might be inhibited by strontium. Additionally, low receptor activator of nuclear factor-κB ligand (RANKL), tumor necrosis factor-α, interleukin-1β, interleukin-6 and p65 immunochemistry staining were observed in strontium-treatment groups. In vitro, strontium obviously decreased osteoclast formation, osteoclastogenesis-related gene expression, osteoclastic bone resorption and pro-inflammatory cytokine expression in bone-marrow-derived macrophages in a dose-dependent manner. Furthermore, we demonstrated that strontium impaired osteoclastogenesis by blocking RANKL-induced activation of NF-κB pathway. In conclusion, our study demonstrated that strontium can significantly inhibit particle-induced osteoclast activation and inflammatory bone loss by disturbing the NF-κB pathway, and is an effective therapeutic agent for the treatment of wear particle-induced aseptic loosening.

1 March 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
ZPZichuan Ping
Zichuan Ping
XHXuanyang Hu
Xuanyang Hu
LWLiangliang Wang
Liangliang Wang
JSJiawei Shi
Jiawei Shi
YTYunxia Tao
Yunxia Tao
DGDechun Geng
Dechun Geng